Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis

Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Fazia A., Juboori, Alhareth Al, Bragg, Jack D., Tahan, Veysel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864712/
https://www.ncbi.nlm.nih.gov/pubmed/29607436
http://dx.doi.org/10.14744/nci.2017.77045
_version_ 1783308537521242112
author Mir, Fazia A.
Juboori, Alhareth Al
Bragg, Jack D.
Tahan, Veysel
author_facet Mir, Fazia A.
Juboori, Alhareth Al
Bragg, Jack D.
Tahan, Veysel
author_sort Mir, Fazia A.
collection PubMed
description Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematological malignancies, and pancytopenia. Autoimmune hemolytic anemia has rarely been reported in ulcerative colitis. Herein we report a case of drug-induced hemolytic anemia after infliximab infusion for treating ulcerative colitis.
format Online
Article
Text
id pubmed-5864712
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-58647122018-03-30 Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis Mir, Fazia A. Juboori, Alhareth Al Bragg, Jack D. Tahan, Veysel North Clin Istanb Case Report Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematological malignancies, and pancytopenia. Autoimmune hemolytic anemia has rarely been reported in ulcerative colitis. Herein we report a case of drug-induced hemolytic anemia after infliximab infusion for treating ulcerative colitis. Kare Publishing 2018-01-11 /pmc/articles/PMC5864712/ /pubmed/29607436 http://dx.doi.org/10.14744/nci.2017.77045 Text en Copyright: © 2018 by Istanbul Northern Anatolian Association of Public Hospitals http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Case Report
Mir, Fazia A.
Juboori, Alhareth Al
Bragg, Jack D.
Tahan, Veysel
Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
title Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
title_full Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
title_fullStr Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
title_full_unstemmed Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
title_short Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
title_sort autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864712/
https://www.ncbi.nlm.nih.gov/pubmed/29607436
http://dx.doi.org/10.14744/nci.2017.77045
work_keys_str_mv AT mirfaziaa autoimmunehemolyticanemiaassociatedwithinfliximabinfusioninulcerativecolitis
AT juboorialharethal autoimmunehemolyticanemiaassociatedwithinfliximabinfusioninulcerativecolitis
AT braggjackd autoimmunehemolyticanemiaassociatedwithinfliximabinfusioninulcerativecolitis
AT tahanveysel autoimmunehemolyticanemiaassociatedwithinfliximabinfusioninulcerativecolitis

Ejemplares similares